J&J Earnings Beat Estimates As Pharma Sales Shine

By | April 15, 2014

Scalper1 News

Johnson & Johnson (JNJ) kicked off the medical industry’s Q1 earnings season with a modest upside surprise Tuesday, sending the stock up 1.5% in morning trading on the stock market today. J&J’s earnings, minus one-time items, totaled $1.54 a share, up 7% from the year-earlier quarter and beating analysts’ consensus by 6 cents. Sales rose 3.5% to $18.1 billion, about $100 million above estimates. The company also added a nickel to its 2014 EPS Scalper1 News

Scalper1 News